<!-- received="Fri Jun  4 11:04:13 1999 MDT" -->
<!-- sent="Fri, 04 Jun 1999 10:00:20 -0700" -->
<!-- name="Elizabeth Childs" -->
<!-- email="echilds@linex.com" -->
<a name="2784qlink1"><!-- subject="Re: beta carotene increases mortality" -->
<!-- id="37580624.15412866@linex.com" -->
<!-- inreplyto="beta carotene increases mortality" -->
<!-- version=1.10, linesinbody=81 -->
<html><head><title>extropians: Re: beta carotene increases mortality</title>
<meta name=author content="Elizabeth Childs">
<link rel=author rev=made href="mailto:echilds@linex.com" title ="Elizabeth Childs">
</head><body>
<h1>Re: beta carotene increases mortality</h1>
Elizabeth Childs (<i>echilds@linex.com</i>)<br>
<i>Fri, 04 Jun 1999 10:00:20 -0700</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#2783">[ date ]</a><a href="index.html#2783">[ thread ]</a><a href="subject.html#2783">[ subject ]</a><a href="author.html#2783">[ author ]</a>
<!-- next="start" -->
<li><a href="2784.html">[ Next ]</a><a href="2782.html">[ Previous ]</a>
<b>In reply to:</b> <a href="2768.html">Doug Skrecky</a>
<!-- nextthread="start" -->
</ul>
<!-- body="start" -->

<p>
So when they say "increases mortality" they mean that the experimental
subjects live longer?

<p>
Doug Skrecky wrote:
<br>
<i>&gt; </i><br>
<a href="2768.html#2783qlink1">&gt; Citations: 1-2</a><br>
<i>&gt; &lt;1&gt;</i><br>
<i>&gt; Authors</i><br>
<i>&gt;   Omenn GS.</i><br>
<i>&gt; Institution</i><br>
<i>&gt;   School of Public Health &amp; Community Medicine, University of Washington,</i><br>
<i>&gt;   Seattle 98195-7230, USA. gomenn@umich.edu</i><br>
<i>&gt; Title</i><br>
<i>&gt;   Chemoprevention of lung cancer: the rise and demise of</i><br>
<i>&gt;   beta-carotene. [Review] [124 refs]</i><br>
<i>&gt; Source</i><br>
<i>&gt;   Annual Review of Public Health.  19:73-99, 1998.</i><br>
<i>&gt; Abstract</i><br>
<i>&gt;   Beta-carotene and retinoids were the most</i><br>
<i>&gt;   promising agents against common cancers when the National Cancer Institute</i><br>
<i>&gt;   mounted a substantial program of population-based trials in the early 1980s.</i><br>
<i>&gt;   Both major lung cancer chemoprevention trials not only showed no benefit, but</i><br>
<i>&gt;   had significant increases in lung cancer incidence and in cardiovascular and</i><br>
<i>&gt;   total mortality. A new generation of laboratory research has</i><br>
<i>&gt;   been stimulated. Rational public health recommendations at this time include:</i><br>
<i>&gt;   1. Five-A-Day servings of fruits and vegetables, a doubling of current mean</i><br>
<i>&gt;   intake; 2. systematic investigation of the covariates of extremes of fruit</i><br>
<i>&gt;   and vegetable intake; 3. discouragement of</i><br>
<i>&gt;   beta-carotene supplement use, due to</i><br>
<i>&gt;   adverse effects in smokers and no evidence of benefit in non-smokers; 4.</i><br>
<i>&gt;   multilevel research to develop and evaluate candidate chemoprevention agents</i><br>
<i>&gt;   to prevent lung and other common cancers; and 5. continued priority for</i><br>
<i>&gt;   smoking prevention, smoking cessation, and avoidance of known carcinogens in</i><br>
<i>&gt;   the environment. [References: 124]</i><br>
<i>&gt; </i><br>
<i>&gt; &lt;2&gt;</i><br>
<i>&gt; Authors</i><br>
<i>&gt;   Heinonen OP.  Albanes D.  Virtamo J.  Taylor PR.  Huttunen JK.  Hartman AM.</i><br>
<i>&gt;   Haapakoski J.  Malila N.  Rautalahti M.  Ripatti S.  Maenpaa H.  Teerenhovi</i><br>
<i>&gt;   L.  Koss L.  Virolainen M.  Edwards BK.</i><br>
<i>&gt; Institution</i><br>
<i>&gt;   Department of Public Health, University of Helsinki, Finland.</i><br>
<i>&gt; Title</i><br>
<i>&gt;   Prostate cancer and supplementation with alpha-tocopherol and</i><br>
<i>&gt;   beta-carotene: incidence and</i><br>
<i>&gt;   mortality in a controlled trial [see comments].</i><br>
<i>&gt; Comments</i><br>
<i>&gt;   Comment in: J Natl Cancer Inst 1998 Mar 18;90(6):414-5, Comment in: J Natl</i><br>
<i>&gt;   Cancer Inst 1998 Mar 18;90(6):416-7</i><br>
<i>&gt; Source</i><br>
<i>&gt;   Journal of the National Cancer Institute.  90(6):440-6, 1998 Mar 18.</i><br>
<i>&gt; Abstract</i><br>
<i>&gt;   BACKGROUND: Epidemiologic studies have suggested that vitamin E and</i><br>
<i>&gt;   beta-carotene may each influence the</i><br>
<i>&gt;   development of prostate cancer. In the Alpha-Tocopherol,</i><br>
<i>&gt;   Beta-Carotene Cancer Prevention Study, a</i><br>
<i>&gt;   controlled trial, we studied the effect of alpha-tocopherol (a form of</i><br>
<i>&gt;   vitamin E) and beta-carotene</i><br>
<i>&gt;   supplementation, separately or together, on prostate cancer in male smokers.</i><br>
<i>&gt;   METHODS: A total of 29133 male smokers aged 50-69 years from southwestern</i><br>
<i>&gt;   Finland were randomly assigned to receive alpha-tocopherol (50 mg),</i><br>
<i>&gt;   beta-carotene (20 mg), both agents, or</i><br>
<i>&gt;   placebo daily for 5-8 years (median, 6.1 years). The supplementation effects</i><br>
<i>&gt;   were estimated by a proportional hazards model, and two-sided P values were</i><br>
<i>&gt;   calculated. RESULTS: We found 246 new cases of and 62 deaths from prostate</i><br>
<i>&gt;   cancer during the follow-up period. A 32% decrease (95% confidence interval</i><br>
<i>&gt;   [CI] = -47% to -12%) in the incidence of prostate cancer was observed among</i><br>
<i>&gt;   the subjects receiving alpha-tocopherol (n = 14564) compared with those not</i><br>
<i>&gt;   receiving it (n = 14569). The reduction was evident in clinical prostate</i><br>
<i>&gt;   cancer but not in latent cancer. Mortality from prostate</i><br>
<i>&gt;   cancer was 41% lower (95% CI = -65% to -1%) among men receiving</i><br>
<i>&gt;   alpha-tocopherol. Among subjects receiving</i><br>
<i>&gt;   beta-carotene (n = 14560), prostate cancer</i><br>
<i>&gt;   incidence was 23% higher (95% CI = -4%-59%) and mortality</i><br>
<i>&gt;   was 15% higher (95% CI = -30%-89%) compared with those not receiving it (n =</i><br>
<i>&gt;   14573). Neither agent had any effect on the time interval between diagnosis</i><br>
<i>&gt;   and death. CONCLUSIONS: Long-term supplementation with alpha-tocopherol</i><br>
<i>&gt;   substantially reduced prostate cancer incidence and</i><br>
<i>&gt;   mortality in male smokers. Other controlled trials are</i><br>
<i>&gt;   required to confirm the findings.</i><br>
</a>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="2784.html">[ Next ]</a><a href="2782.html">[ Previous ]</a>
<b>In reply to:</b> <a href="2768.html">Doug Skrecky</a>
<!-- nextthread="start" -->
</ul>
</body></html>
